A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 52-Week, Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Non-Cystic Fibrosis Bronchiectasis (MAHALE)

Project: Research

Project Details

StatusActive
Effective start/end date22/06/2131/12/24

Keywords

  • Non-Cystic Fibrosis Bronchiectasis
  • Respiratory medicine
  • Clinical trial